BioFire
BioMérieux Respiratory/Sore Throat Mini Panel Gets FDA Special 510(k) Clearance, CLIA Waiver
The firm said that it expects its SpotFire Respiratory/Sore Throat (R/ST) Panel Mini test to be available in the US in the third quarter of 2024.
ESCMID Global Panelists Underscore Role of Rapid Dx Testing in Antimicrobial Resistance Battle
Premium
In a BioMérieux-sponsored symposium, economist Lord Jim O'Neill revisited a 2016 report on AMR while experts discussed the use of rapid testing tools such as those offered by the French company.
BioMérieux Q3 Revenues Dip Slightly
The firm confirmed its full-year guidance for organic sales growth of between 4 percent and 6 percent.
Top Five Articles on 360Dx Last Week: Siemens Healthineers Layoffs and Atellica Focus; and More
Last week, readers were most interested in a story about changes at Siemens Healthineers as it plans to shut down some of its legacy instruments.
BioMérieux Gets CLIA Waiver for BioFire SpotFire Respiratory Panel Mini
The CLIA waiver now allows the SpotFire system and two existing panels to be used by non-lab professionals at the point of care, the firm said.